

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of meiosis I (GO:0060631) | 6.20489055 |
| 2 | proteasome assembly (GO:0043248) | 5.18832801 |
| 3 | histone H2A ubiquitination (GO:0033522) | 4.27420451 |
| 4 | Golgi transport vesicle coating (GO:0048200) | 4.18751610 |
| 5 | COPI coating of Golgi vesicle (GO:0048205) | 4.18751610 |
| 6 | ribosome assembly (GO:0042255) | 4.07049213 |
| 7 | DNA double-strand break processing (GO:0000729) | 4.02405645 |
| 8 | ER overload response (GO:0006983) | 3.93864309 |
| 9 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.84969164 |
| 10 | nuclear pore organization (GO:0006999) | 3.62496521 |
| 11 | ribonucleoprotein complex disassembly (GO:0032988) | 3.61798931 |
| 12 | nuclear pore complex assembly (GO:0051292) | 3.61525461 |
| 13 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 3.59536790 |
| 14 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 3.59536790 |
| 15 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 3.59536790 |
| 16 | macroautophagy (GO:0016236) | 3.58349977 |
| 17 | organelle disassembly (GO:1903008) | 3.56275460 |
| 18 | positive regulation by symbiont of host defense response (GO:0052509) | 3.46867895 |
| 19 | modulation by symbiont of host defense response (GO:0052031) | 3.46867895 |
| 20 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.46867895 |
| 21 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.46867895 |
| 22 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.46867895 |
| 23 | modulation by symbiont of host immune response (GO:0052553) | 3.46867895 |
| 24 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.42701160 |
| 25 | non-recombinational repair (GO:0000726) | 3.42701160 |
| 26 | response to peptidoglycan (GO:0032494) | 3.40925968 |
| 27 | ether lipid metabolic process (GO:0046485) | 3.34897458 |
| 28 | kynurenine metabolic process (GO:0070189) | 3.29739075 |
| 29 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.25223964 |
| 30 | growth hormone receptor signaling pathway (GO:0060396) | 3.22454221 |
| 31 | neutrophil activation involved in immune response (GO:0002283) | 3.21565976 |
| 32 | neutrophil mediated immunity (GO:0002446) | 3.18123688 |
| 33 | ER to Golgi vesicle-mediated transport (GO:0006888) | 3.17890236 |
| 34 | piRNA metabolic process (GO:0034587) | 3.09888427 |
| 35 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 3.07064605 |
| 36 | isotype switching (GO:0045190) | 3.07064605 |
| 37 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 3.07064605 |
| 38 | histone mRNA catabolic process (GO:0071044) | 3.00330117 |
| 39 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.99114167 |
| 40 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.97679409 |
| 41 | tryptophan catabolic process (GO:0006569) | 2.97643564 |
| 42 | indole-containing compound catabolic process (GO:0042436) | 2.97643564 |
| 43 | indolalkylamine catabolic process (GO:0046218) | 2.97643564 |
| 44 | positive regulation of protein autophosphorylation (GO:0031954) | 2.97608040 |
| 45 | maturation of 5.8S rRNA (GO:0000460) | 2.97526871 |
| 46 | phagosome maturation (GO:0090382) | 2.94768977 |
| 47 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.94480045 |
| 48 | synapsis (GO:0007129) | 2.93706280 |
| 49 | macrophage activation involved in immune response (GO:0002281) | 2.91174075 |
| 50 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.90592974 |
| 51 | regulation of fever generation (GO:0031620) | 2.89882294 |
| 52 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.87524877 |
| 53 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.86618041 |
| 54 | pore complex assembly (GO:0046931) | 2.86463411 |
| 55 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.83719116 |
| 56 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.82174610 |
| 57 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.82174610 |
| 58 | regulation of heat generation (GO:0031650) | 2.81731293 |
| 59 | glycerol ether metabolic process (GO:0006662) | 2.80925494 |
| 60 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.80084632 |
| 61 | protein K11-linked deubiquitination (GO:0035871) | 2.79538383 |
| 62 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.75923097 |
| 63 | myeloid leukocyte mediated immunity (GO:0002444) | 2.75290674 |
| 64 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.75133082 |
| 65 | Rap protein signal transduction (GO:0032486) | 2.74832087 |
| 66 | tryptophan metabolic process (GO:0006568) | 2.73550941 |
| 67 | sequestering of metal ion (GO:0051238) | 2.73221370 |
| 68 | cell adhesion mediated by integrin (GO:0033627) | 2.72726063 |
| 69 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.72463851 |
| 70 | positive regulation of interferon-alpha production (GO:0032727) | 2.70475718 |
| 71 | cullin deneddylation (GO:0010388) | 2.70322783 |
| 72 | glycoprotein catabolic process (GO:0006516) | 2.70045537 |
| 73 | cellular response to growth hormone stimulus (GO:0071378) | 2.69537587 |
| 74 | vesicle coating (GO:0006901) | 2.68685584 |
| 75 | protein localization to cell surface (GO:0034394) | 2.67930628 |
| 76 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.66754604 |
| 77 | positive regulation of heat generation (GO:0031652) | 2.63792955 |
| 78 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 2.63604377 |
| 79 | protein K63-linked deubiquitination (GO:0070536) | 2.62769457 |
| 80 | protein deneddylation (GO:0000338) | 2.62719473 |
| 81 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.61348353 |
| 82 | centriole replication (GO:0007099) | 2.61339892 |
| 83 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.60582877 |
| 84 | long-term synaptic potentiation (GO:0060291) | 2.58879382 |
| 85 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.57336373 |
| 86 | regulation of prostaglandin secretion (GO:0032306) | 2.56169317 |
| 87 | signal peptide processing (GO:0006465) | 2.55055207 |
| 88 | negative regulation of lipid storage (GO:0010888) | 2.53691189 |
| 89 | regulation of interferon-alpha production (GO:0032647) | 2.53563418 |
| 90 | lactate metabolic process (GO:0006089) | 2.52828532 |
| 91 | microglial cell activation (GO:0001774) | 2.51463159 |
| 92 | multicellular organism reproduction (GO:0032504) | 2.50925804 |
| 93 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.50060376 |
| 94 | response to host immune response (GO:0052572) | 2.50060376 |
| 95 | neural tube formation (GO:0001841) | 2.49748925 |
| 96 | glycosphingolipid catabolic process (GO:0046479) | 2.49570098 |
| 97 | mitochondrial DNA replication (GO:0006264) | 2.49232363 |
| 98 | response to X-ray (GO:0010165) | 2.49222111 |
| 99 | ether metabolic process (GO:0018904) | 2.49055398 |
| 100 | negative regulation of signal transduction by p53 class mediator (GO:1901797) | 2.48513835 |
| 101 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.47169534 |
| 102 | transferrin transport (GO:0033572) | 2.47035851 |
| 103 | protein targeting to Golgi (GO:0000042) | 2.46840391 |
| 104 | apoptotic cell clearance (GO:0043277) | 2.46431998 |
| 105 | rRNA catabolic process (GO:0016075) | 2.46371027 |
| 106 | ferric iron transport (GO:0015682) | 2.44849646 |
| 107 | trivalent inorganic cation transport (GO:0072512) | 2.44849646 |
| 108 | Golgi to endosome transport (GO:0006895) | 2.43984226 |
| 109 | substrate-dependent cell migration (GO:0006929) | 2.43870060 |
| 110 | insulin secretion (GO:0030073) | 2.43447047 |
| 111 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.42580746 |
| 112 | protein prenylation (GO:0018342) | 2.41992506 |
| 113 | prenylation (GO:0097354) | 2.41992506 |
| 114 | negative regulation of neurotransmitter transport (GO:0051589) | 2.41050770 |
| 115 | regulation of centriole replication (GO:0046599) | 2.40305896 |
| 116 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.40146600 |
| 117 | protein K48-linked deubiquitination (GO:0071108) | 2.40030053 |
| 118 | glycolipid catabolic process (GO:0019377) | 2.39969105 |
| 119 | primitive streak formation (GO:0090009) | 2.39525905 |
| 120 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.39297658 |
| 121 | regulation of protein polyubiquitination (GO:1902914) | 2.39016572 |
| 122 | neutrophil activation (GO:0042119) | 2.38582155 |
| 123 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.38101009 |
| 124 | establishment of protein localization to Golgi (GO:0072600) | 2.37830776 |
| 125 | meiotic cell cycle (GO:0051321) | 2.37585978 |
| 126 | metaphase plate congression (GO:0051310) | 2.37241982 |
| 127 | negative regulation of mast cell activation (GO:0033004) | 2.36645311 |
| 128 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.36220812 |
| 129 | ganglion development (GO:0061548) | 2.36048349 |
| 130 | DNA methylation involved in gamete generation (GO:0043046) | 2.35745008 |
| 131 | vesicle transport along microtubule (GO:0047496) | 2.34789934 |
| 132 | nucleotide-sugar metabolic process (GO:0009225) | 2.34525258 |
| 133 | establishment of chromosome localization (GO:0051303) | 2.34362852 |
| 134 | iron ion transport (GO:0006826) | 2.34134668 |
| 135 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.32935413 |
| 136 | presynaptic membrane assembly (GO:0097105) | 2.31786030 |
| 137 | negative regulation of interleukin-17 production (GO:0032700) | 2.30961622 |
| 138 | neuron cell-cell adhesion (GO:0007158) | 2.29718086 |
| 139 | germ cell migration (GO:0008354) | 2.29508391 |
| 140 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.29208382 |
| 141 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.29073412 |
| 142 | granulocyte activation (GO:0036230) | 2.28807380 |
| 143 | positive regulation of chromosome segregation (GO:0051984) | 2.28187368 |
| 144 | positive regulation of histone H3-K4 methylation (GO:0051571) | 2.28016099 |
| 145 | nerve growth factor signaling pathway (GO:0038180) | 2.27438011 |
| 146 | protein neddylation (GO:0045116) | 2.27254717 |
| 147 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 2.26895826 |
| 148 | locomotory exploration behavior (GO:0035641) | 2.26772200 |
| 149 | keratan sulfate catabolic process (GO:0042340) | 2.26571667 |
| 150 | inner ear receptor cell development (GO:0060119) | 2.26245476 |
| 151 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.26238801 |
| 152 | negative regulation of exocytosis (GO:0045920) | 2.25283978 |
| 153 | iron ion import (GO:0097286) | 2.24639707 |
| 154 | positive regulation of vesicle fusion (GO:0031340) | 2.24398551 |
| 155 | COPII vesicle coating (GO:0048208) | 2.24328984 |
| 156 | regulation of protein autophosphorylation (GO:0031952) | 2.24118475 |
| 157 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.23903277 |
| 158 | regulation of fibroblast apoptotic process (GO:2000269) | 2.23423048 |
| 159 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.23093893 |
| 160 | somatic recombination of immunoglobulin gene segments (GO:0016447) | 2.23039490 |
| 161 | type B pancreatic cell development (GO:0003323) | 2.22842089 |
| 162 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.22759995 |
| 163 | fibroblast migration (GO:0010761) | 2.22516443 |
| 164 | early endosome to late endosome transport (GO:0045022) | 2.22468693 |
| 165 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.22336962 |
| 166 | lipid particle organization (GO:0034389) | 2.21785193 |
| 167 | positive regulation of meiotic cell cycle (GO:0051446) | 2.20554238 |
| 168 | regulation of histone H3-K9 methylation (GO:0051570) | 2.20317393 |
| 169 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.19737555 |
| 170 | regulation of DNA methylation (GO:0044030) | 2.19625163 |
| 171 | blastocyst development (GO:0001824) | 2.19152858 |
| 172 | myelin assembly (GO:0032288) | 2.19078839 |
| 173 | regulation of establishment of cell polarity (GO:2000114) | 2.19017029 |
| 174 | regulation of metalloenzyme activity (GO:0048552) | 2.18915447 |
| 175 | somite rostral/caudal axis specification (GO:0032525) | 2.18906128 |
| 176 | positive regulation of meiosis (GO:0045836) | 2.18868005 |
| 177 | response to host (GO:0075136) | 2.18763060 |
| 178 | response to host defenses (GO:0052200) | 2.18763060 |
| 179 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.18763060 |
| 180 | positive regulation of macrophage cytokine production (GO:0060907) | 2.17896638 |
| 181 | macrophage activation (GO:0042116) | 2.17872210 |
| 182 | mitotic metaphase plate congression (GO:0007080) | 2.16169306 |
| 183 | histone H2A monoubiquitination (GO:0035518) | 2.15673479 |
| 184 | chondroitin sulfate catabolic process (GO:0030207) | 2.15113528 |
| 185 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.14479944 |
| 186 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.14391231 |
| 187 | ceramide catabolic process (GO:0046514) | 2.13822194 |
| 188 | positive regulation of macroautophagy (GO:0016239) | 2.12394467 |
| 189 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.12309578 |
| 190 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.11681285 |
| 191 | chondrocyte development (GO:0002063) | 2.11556891 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.69464018 |
| 2 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.96032026 |
| 3 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.91291117 |
| 4 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.61867729 |
| 5 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.45029448 |
| 6 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.41478430 |
| 7 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.36310613 |
| 8 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.29272492 |
| 9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.28556193 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.28479332 |
| 11 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.24935852 |
| 12 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.23447322 |
| 13 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.15383985 |
| 14 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.11649002 |
| 15 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.06491581 |
| 16 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.00590104 |
| 17 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.98015261 |
| 18 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.97669282 |
| 19 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.94833366 |
| 20 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.92534847 |
| 21 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.89677928 |
| 22 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.87444425 |
| 23 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.84978792 |
| 24 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.84978792 |
| 25 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.82845767 |
| 26 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.82097489 |
| 27 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.79070493 |
| 28 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.75287317 |
| 29 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.73332425 |
| 30 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.72601405 |
| 31 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.66872879 |
| 32 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.66790502 |
| 33 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.66047166 |
| 34 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.62116316 |
| 35 | TP53_16413492_ChIP-PET_HCT116_Human | 1.61752083 |
| 36 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.61299921 |
| 37 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.60554527 |
| 38 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.59175888 |
| 39 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.58461233 |
| 40 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.53746846 |
| 41 | VDR_22108803_ChIP-Seq_LS180_Human | 1.52644918 |
| 42 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.51625719 |
| 43 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.49781313 |
| 44 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.49656579 |
| 45 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.47096919 |
| 46 | P300_19829295_ChIP-Seq_ESCs_Human | 1.47001934 |
| 47 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.46674613 |
| 48 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.46342119 |
| 49 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.45896742 |
| 50 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.45128255 |
| 51 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.45090363 |
| 52 | STAT3_23295773_ChIP-Seq_U87_Human | 1.44502973 |
| 53 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.43734130 |
| 54 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.43400276 |
| 55 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.42908985 |
| 56 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.42302630 |
| 57 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.42007639 |
| 58 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.41925364 |
| 59 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.41923510 |
| 60 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.40652035 |
| 61 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.40590574 |
| 62 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.39753951 |
| 63 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.39532352 |
| 64 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.38766271 |
| 65 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.38525258 |
| 66 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.38352346 |
| 67 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.37670568 |
| 68 | FUS_26573619_Chip-Seq_HEK293_Human | 1.37580846 |
| 69 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.37016839 |
| 70 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.36376141 |
| 71 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.35220919 |
| 72 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.34511719 |
| 73 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.31383311 |
| 74 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.30111037 |
| 75 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.28920065 |
| 76 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.28912697 |
| 77 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.28175911 |
| 78 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.28023582 |
| 79 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.27636327 |
| 80 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.23679975 |
| 81 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.23405844 |
| 82 | RXR_22108803_ChIP-Seq_LS180_Human | 1.23198641 |
| 83 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.22889664 |
| 84 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.22011002 |
| 85 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.21143118 |
| 86 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.20074046 |
| 87 | GATA1_22025678_ChIP-Seq_K562_Human | 1.19830979 |
| 88 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.18910508 |
| 89 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.18822873 |
| 90 | AR_25329375_ChIP-Seq_VCAP_Human | 1.17311054 |
| 91 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16273477 |
| 92 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.14183986 |
| 93 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.13930602 |
| 94 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.13096215 |
| 95 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.12689526 |
| 96 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.12457743 |
| 97 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.12410982 |
| 98 | EWS_26573619_Chip-Seq_HEK293_Human | 1.12083445 |
| 99 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.10360969 |
| 100 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.09998150 |
| 101 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.09981918 |
| 102 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.09351314 |
| 103 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08955161 |
| 104 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.08742823 |
| 105 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.07934520 |
| 106 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.07914078 |
| 107 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.06568696 |
| 108 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.06210872 |
| 109 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.06197562 |
| 110 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.05839340 |
| 111 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.05559813 |
| 112 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.05223785 |
| 113 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.05209984 |
| 114 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.04631825 |
| 115 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.04410202 |
| 116 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.03499282 |
| 117 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.03144263 |
| 118 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.03037091 |
| 119 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.02939127 |
| 120 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.02604035 |
| 121 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.01907817 |
| 122 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.01173749 |
| 123 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.00704286 |
| 124 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.99908791 |
| 125 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.99177269 |
| 126 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.99136604 |
| 127 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.98798957 |
| 128 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.98798957 |
| 129 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.98530118 |
| 130 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.98286868 |
| 131 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.97787467 |
| 132 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.97201378 |
| 133 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.96933066 |
| 134 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.95469953 |
| 135 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.95287563 |
| 136 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.95201858 |
| 137 | * IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.94872857 |
| 138 | * CBP_20019798_ChIP-Seq_JUKART_Human | 0.94872857 |
| 139 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.94489024 |
| 140 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93637683 |
| 141 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.93485239 |
| 142 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.93422339 |
| 143 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.92496606 |
| 144 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.91963548 |
| 145 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.91930337 |
| 146 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91715114 |
| 147 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.91425547 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 5.32864709 |
| 2 | MP0003950_abnormal_plasma_membrane | 4.97601070 |
| 3 | MP0003172_abnormal_lysosome_physiology | 3.67062063 |
| 4 | MP0006054_spinal_hemorrhage | 3.62837872 |
| 5 | MP0003718_maternal_effect | 3.31507411 |
| 6 | MP0003283_abnormal_digestive_organ | 3.18595135 |
| 7 | MP0008438_abnormal_cutaneous_collagen | 3.15318217 |
| 8 | MP0003183_abnormal_peptide_metabolism | 2.99303791 |
| 9 | MP0002877_abnormal_melanocyte_morpholog | 2.90940550 |
| 10 | MP0009780_abnormal_chondrocyte_physiolo | 2.76367703 |
| 11 | MP0005257_abnormal_intraocular_pressure | 2.73820874 |
| 12 | MP0003656_abnormal_erythrocyte_physiolo | 2.67477224 |
| 13 | MP0004147_increased_porphyrin_level | 2.63569272 |
| 14 | MP0002638_abnormal_pupillary_reflex | 2.62078872 |
| 15 | MP0005171_absent_coat_pigmentation | 2.53060411 |
| 16 | MP0005058_abnormal_lysosome_morphology | 2.50722529 |
| 17 | MP0010386_abnormal_urinary_bladder | 2.37914939 |
| 18 | MP0008057_abnormal_DNA_replication | 2.33387558 |
| 19 | MP0008058_abnormal_DNA_repair | 2.17743350 |
| 20 | MP0005275_abnormal_skin_tensile | 2.16190467 |
| 21 | MP0003252_abnormal_bile_duct | 2.14464207 |
| 22 | MP0005085_abnormal_gallbladder_physiolo | 2.10046938 |
| 23 | MP0005076_abnormal_cell_differentiation | 2.05405279 |
| 24 | MP0009697_abnormal_copulation | 2.04059263 |
| 25 | MP0003303_peritoneal_inflammation | 1.92443360 |
| 26 | MP0003566_abnormal_cell_adhesion | 1.88298767 |
| 27 | MP0001188_hyperpigmentation | 1.85442732 |
| 28 | MP0004957_abnormal_blastocyst_morpholog | 1.85352220 |
| 29 | MP0003191_abnormal_cellular_cholesterol | 1.82723412 |
| 30 | MP0000013_abnormal_adipose_tissue | 1.81936670 |
| 31 | MP0010678_abnormal_skin_adnexa | 1.81650452 |
| 32 | MP0000427_abnormal_hair_cycle | 1.78715523 |
| 33 | MP0002909_abnormal_adrenal_gland | 1.77418460 |
| 34 | MP0003941_abnormal_skin_development | 1.75865200 |
| 35 | MP0003091_abnormal_cell_migration | 1.73061240 |
| 36 | MP0005503_abnormal_tendon_morphology | 1.72843433 |
| 37 | MP0003436_decreased_susceptibility_to | 1.69849678 |
| 38 | MP0002419_abnormal_innate_immunity | 1.65413808 |
| 39 | MP0004858_abnormal_nervous_system | 1.63254370 |
| 40 | MP0001533_abnormal_skeleton_physiology | 1.62201768 |
| 41 | MP0004134_abnormal_chest_morphology | 1.61638216 |
| 42 | MP0005310_abnormal_salivary_gland | 1.57977388 |
| 43 | MP0003705_abnormal_hypodermis_morpholog | 1.55024924 |
| 44 | MP0006082_CNS_inflammation | 1.51980246 |
| 45 | MP0009278_abnormal_bone_marrow | 1.51344531 |
| 46 | MP0002693_abnormal_pancreas_physiology | 1.51195090 |
| 47 | MP0008877_abnormal_DNA_methylation | 1.50687356 |
| 48 | MP0008875_abnormal_xenobiotic_pharmacok | 1.47920997 |
| 49 | MP0005084_abnormal_gallbladder_morpholo | 1.47892212 |
| 50 | MP0003186_abnormal_redox_activity | 1.47217918 |
| 51 | MP0005395_other_phenotype | 1.42391197 |
| 52 | MP0000015_abnormal_ear_pigmentation | 1.41401149 |
| 53 | MP0002998_abnormal_bone_remodeling | 1.40397236 |
| 54 | MP0003300_gastrointestinal_ulcer | 1.37667260 |
| 55 | MP0001324_abnormal_eye_pigmentation | 1.36435237 |
| 56 | MP0008007_abnormal_cellular_replicative | 1.36001644 |
| 57 | MP0000647_abnormal_sebaceous_gland | 1.35248421 |
| 58 | MP0001501_abnormal_sleep_pattern | 1.34466982 |
| 59 | MP0010368_abnormal_lymphatic_system | 1.30915705 |
| 60 | MP0005164_abnormal_response_to | 1.29676168 |
| 61 | MP0003634_abnormal_glial_cell | 1.27920283 |
| 62 | MP0003690_abnormal_glial_cell | 1.26618554 |
| 63 | MP0008775_abnormal_heart_ventricle | 1.26068490 |
| 64 | MP0005174_abnormal_tail_pigmentation | 1.25041161 |
| 65 | MP0001666_abnormal_nutrient_absorption | 1.24017962 |
| 66 | MP0001835_abnormal_antigen_presentation | 1.21454697 |
| 67 | MP0000383_abnormal_hair_follicle | 1.20550400 |
| 68 | MP0005408_hypopigmentation | 1.19732321 |
| 69 | MP0010094_abnormal_chromosome_stability | 1.19516014 |
| 70 | MP0005360_urolithiasis | 1.19034692 |
| 71 | MP0005390_skeleton_phenotype | 1.17950502 |
| 72 | MP0002138_abnormal_hepatobiliary_system | 1.17107080 |
| 73 | MP0000371_diluted_coat_color | 1.16957867 |
| 74 | MP0006072_abnormal_retinal_apoptosis | 1.14540269 |
| 75 | MP0002102_abnormal_ear_morphology | 1.14284946 |
| 76 | MP0002254_reproductive_system_inflammat | 1.14215507 |
| 77 | MP0002139_abnormal_hepatobiliary_system | 1.13528414 |
| 78 | MP0004272_abnormal_basement_membrane | 1.11777643 |
| 79 | MP0003221_abnormal_cardiomyocyte_apopto | 1.11035601 |
| 80 | MP0003890_abnormal_embryonic-extraembry | 1.10487877 |
| 81 | MP0004510_myositis | 1.09995981 |
| 82 | MP0005187_abnormal_penis_morphology | 1.09924125 |
| 83 | MP0010234_abnormal_vibrissa_follicle | 1.09713776 |
| 84 | MP0008932_abnormal_embryonic_tissue | 1.09712468 |
| 85 | MP0004130_abnormal_muscle_cell | 1.09164444 |
| 86 | MP0005197_abnormal_uvea_morphology | 1.08862654 |
| 87 | MP0001299_abnormal_eye_distance/ | 1.06915140 |
| 88 | MP0003868_abnormal_feces_composition | 1.05516765 |
| 89 | MP0005367_renal/urinary_system_phenotyp | 1.05336189 |
| 90 | MP0000516_abnormal_urinary_system | 1.05336189 |
| 91 | MP0002896_abnormal_bone_mineralization | 1.05078688 |
| 92 | MP0004947_skin_inflammation | 1.02932597 |
| 93 | MP0001542_abnormal_bone_strength | 1.01933800 |
| 94 | MP0002060_abnormal_skin_morphology | 1.01505150 |
| 95 | MP0003279_aneurysm | 1.00348796 |
| 96 | MP0001944_abnormal_pancreas_morphology | 1.00168507 |
| 97 | MP0005023_abnormal_wound_healing | 0.99650804 |
| 98 | MP0005000_abnormal_immune_tolerance | 0.99284822 |
| 99 | MP0003045_fibrosis | 0.99038833 |
| 100 | MP0002876_abnormal_thyroid_physiology | 0.97688197 |
| 101 | MP0001929_abnormal_gametogenesis | 0.96178360 |
| 102 | MP0005365_abnormal_bile_salt | 0.95087449 |
| 103 | MP0003077_abnormal_cell_cycle | 0.94914647 |
| 104 | MP0000358_abnormal_cell_content/ | 0.93778476 |
| 105 | MP0000920_abnormal_myelination | 0.93266143 |
| 106 | MP0003448_altered_tumor_morphology | 0.90223609 |
| 107 | MP0005410_abnormal_fertilization | 0.89368688 |
| 108 | MP0001661_extended_life_span | 0.89085706 |
| 109 | MP0002332_abnormal_exercise_endurance | 0.87454789 |
| 110 | MP0002168_other_aberrant_phenotype | 0.87309004 |
| 111 | MP0004215_abnormal_myocardial_fiber | 0.86876222 |
| 112 | MP0002084_abnormal_developmental_patter | 0.86712881 |
| 113 | MP0001191_abnormal_skin_condition | 0.86610213 |
| 114 | MP0002928_abnormal_bile_duct | 0.86127390 |
| 115 | MP0008260_abnormal_autophagy | 0.86010604 |
| 116 | MP0003795_abnormal_bone_structure | 0.85991749 |
| 117 | MP0004883_abnormal_blood_vessel | 0.85806300 |
| 118 | MP0003693_abnormal_embryo_hatching | 0.85796779 |
| 119 | MP0001186_pigmentation_phenotype | 0.85644476 |
| 120 | MP0004264_abnormal_extraembryonic_tissu | 0.85483091 |
| 121 | MP0005508_abnormal_skeleton_morphology | 0.85398943 |
| 122 | MP0003195_calcinosis | 0.85131634 |
| 123 | MP0002090_abnormal_vision | 0.85031213 |
| 124 | MP0001730_embryonic_growth_arrest | 0.82353435 |
| 125 | MP0001958_emphysema | 0.82244281 |
| 126 | MP0010307_abnormal_tumor_latency | 0.81479051 |
| 127 | MP0005319_abnormal_enzyme/_coenzyme | 0.80680600 |
| 128 | MP0005645_abnormal_hypothalamus_physiol | 0.79453795 |
| 129 | MP0002452_abnormal_antigen_presenting | 0.79352745 |
| 130 | MP0009785_altered_susceptibility_to | 0.78682396 |
| 131 | MP0003699_abnormal_female_reproductive | 0.78101719 |
| 132 | MP0000343_altered_response_to | 0.77866368 |
| 133 | MP0001243_abnormal_dermal_layer | 0.77671763 |
| 134 | MP0001879_abnormal_lymphatic_vessel | 0.77651607 |
| 135 | MP0002086_abnormal_extraembryonic_tissu | 0.76893310 |
| 136 | MP0004859_abnormal_synaptic_plasticity | 0.76294410 |
| 137 | MP0000733_abnormal_muscle_development | 0.76267769 |
| 138 | MP0005332_abnormal_amino_acid | 0.76010511 |
| 139 | MP0000653_abnormal_sex_gland | 0.75507158 |
| 140 | MP0002063_abnormal_learning/memory/cond | 0.75492774 |
| 141 | MP0004270_analgesia | 0.74574196 |
| 142 | MP0008789_abnormal_olfactory_epithelium | 0.74471848 |
| 143 | MP0002148_abnormal_hypersensitivity_rea | 0.74360141 |
| 144 | MP0002108_abnormal_muscle_morphology | 0.74332368 |
| 145 | MP0000372_irregular_coat_pigmentation | 0.74165626 |
| 146 | MP0002295_abnormal_pulmonary_circulatio | 0.73647368 |
| 147 | MP0003635_abnormal_synaptic_transmissio | 0.73508078 |
| 148 | MP0001697_abnormal_embryo_size | 0.71914259 |
| 149 | MP0008004_abnormal_stomach_pH | 0.71337282 |
| 150 | MP0010329_abnormal_lipoprotein_level | 0.71213201 |
| 151 | MP0005464_abnormal_platelet_physiology | 0.70426947 |
| 152 | MP0001915_intracranial_hemorrhage | 0.70070506 |
| 153 | MP0003724_increased_susceptibility_to | 0.69277686 |
| 154 | MP0009840_abnormal_foam_cell | 0.69089006 |
| 155 | MP0010352_gastrointestinal_tract_polyps | 0.68952185 |
| 156 | MP0004043_abnormal_pH_regulation | 0.68935573 |
| 157 | MP0002115_abnormal_skeleton_extremities | 0.68414234 |
| 158 | MP0003786_premature_aging | 0.67837616 |
| 159 | MP0004084_abnormal_cardiac_muscle | 0.67712916 |
| 160 | MP0005535_abnormal_body_temperature | 0.67662552 |
| 161 | MP0003075_altered_response_to | 0.67086343 |
| 162 | MP0001119_abnormal_female_reproductive | 0.66367332 |
| 163 | MP0003937_abnormal_limbs/digits/tail_de | 0.66204818 |
| 164 | MP0005647_abnormal_sex_gland | 0.65226689 |
| 165 | MP0005376_homeostasis/metabolism_phenot | 0.65036547 |
| 166 | MP0005621_abnormal_cell_physiology | 0.64965898 |
| 167 | MP0000538_abnormal_urinary_bladder | 0.64065376 |
| 168 | MP0001764_abnormal_homeostasis | 0.64009108 |
| 169 | MP0003828_pulmonary_edema | 0.63662894 |
| 170 | MP0001849_ear_inflammation | 0.63607073 |
| 171 | MP0005167_abnormal_blood-brain_barrier | 0.63552693 |
| 172 | MP0005384_cellular_phenotype | 0.63266738 |
| 173 | MP0004185_abnormal_adipocyte_glucose | 0.62592592 |
| 174 | MP0002837_dystrophic_cardiac_calcinosis | 0.61814058 |
| 175 | MP0002078_abnormal_glucose_homeostasis | 0.59806184 |
| 176 | MP0005253_abnormal_eye_physiology | 0.58726343 |
| 177 | MP0000465_gastrointestinal_hemorrhage | 0.58690299 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Posterior subcapsular cataract (HP:0007787) | 4.55876660 |
| 2 | Tetraparesis (HP:0002273) | 4.17217576 |
| 3 | Increased cerebral lipofuscin (HP:0011813) | 4.14269092 |
| 4 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.97612662 |
| 5 | Recurrent abscess formation (HP:0002722) | 3.52935930 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 3.32830789 |
| 7 | Methylmalonic acidemia (HP:0002912) | 3.30014867 |
| 8 | Eczematoid dermatitis (HP:0000976) | 3.24444686 |
| 9 | Epiphyseal dysplasia (HP:0002656) | 3.14967286 |
| 10 | Absent eyebrow (HP:0002223) | 3.01092476 |
| 11 | Submucous cleft hard palate (HP:0000176) | 2.99078254 |
| 12 | Volvulus (HP:0002580) | 2.89524948 |
| 13 | Metaphyseal dysplasia (HP:0100255) | 2.89302653 |
| 14 | Subcapsular cataract (HP:0000523) | 2.87716060 |
| 15 | Fair hair (HP:0002286) | 2.86649966 |
| 16 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.86539730 |
| 17 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.84546722 |
| 18 | Follicular hyperkeratosis (HP:0007502) | 2.76446410 |
| 19 | Intrahepatic cholestasis (HP:0001406) | 2.73867239 |
| 20 | Persistence of primary teeth (HP:0006335) | 2.69310943 |
| 21 | Supernumerary spleens (HP:0009799) | 2.68872259 |
| 22 | Dysostosis multiplex (HP:0000943) | 2.67408437 |
| 23 | Progressive visual loss (HP:0000529) | 2.66129527 |
| 24 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.62669089 |
| 25 | Mucopolysacchariduria (HP:0008155) | 2.62669089 |
| 26 | Thyroid carcinoma (HP:0002890) | 2.62641674 |
| 27 | Small epiphyses (HP:0010585) | 2.60360816 |
| 28 | Abnormality of methionine metabolism (HP:0010901) | 2.59395125 |
| 29 | Gingivitis (HP:0000230) | 2.56548276 |
| 30 | Abnormality of vitamin B metabolism (HP:0004340) | 2.55920478 |
| 31 | Biliary tract neoplasm (HP:0100574) | 2.54916880 |
| 32 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.52191974 |
| 33 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.52191974 |
| 34 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.52191974 |
| 35 | Short middle phalanx of the 5th finger (HP:0004220) | 2.51035338 |
| 36 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.49103791 |
| 37 | Aplasia/Hypoplasia of the middle phalanx of the 5th finger (HP:0009161) | 2.48558105 |
| 38 | Hematochezia (HP:0002573) | 2.47941848 |
| 39 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.47512146 |
| 40 | Hypoplasia of the odontoid process (HP:0003311) | 2.47497857 |
| 41 | Hypoplastic ischia (HP:0003175) | 2.47493514 |
| 42 | Disinhibition (HP:0000734) | 2.43613217 |
| 43 | Cervical subluxation (HP:0003308) | 2.42117134 |
| 44 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 2.40458034 |
| 45 | Steatorrhea (HP:0002570) | 2.38921240 |
| 46 | Short tibia (HP:0005736) | 2.38487200 |
| 47 | Macroorchidism (HP:0000053) | 2.38467323 |
| 48 | Global brain atrophy (HP:0002283) | 2.38258883 |
| 49 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.37779626 |
| 50 | Abnormality of the odontoid process (HP:0003310) | 2.37111511 |
| 51 | Coarse hair (HP:0002208) | 2.34666113 |
| 52 | Type I transferrin isoform profile (HP:0003642) | 2.34623868 |
| 53 | Abnormal protein glycosylation (HP:0012346) | 2.33108959 |
| 54 | Abnormal glycosylation (HP:0012345) | 2.33108959 |
| 55 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.33108959 |
| 56 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.33108959 |
| 57 | Gonadotropin excess (HP:0000837) | 2.31580638 |
| 58 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.30834543 |
| 59 | Abnormality of glycolipid metabolism (HP:0010969) | 2.29345197 |
| 60 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.29345197 |
| 61 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.29345197 |
| 62 | Abnormality of the ischium (HP:0003174) | 2.28799487 |
| 63 | Abnormal spermatogenesis (HP:0008669) | 2.28187051 |
| 64 | Osteolytic defects of the hand bones (HP:0009699) | 2.21721425 |
| 65 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.21721425 |
| 66 | Akinesia (HP:0002304) | 2.20875386 |
| 67 | Thick nail (HP:0001805) | 2.20199256 |
| 68 | Abnormality of proline metabolism (HP:0010907) | 2.20105938 |
| 69 | Hydroxyprolinuria (HP:0003080) | 2.20105938 |
| 70 | Hypoplasia of the uterus (HP:0000013) | 2.19912329 |
| 71 | Fat malabsorption (HP:0002630) | 2.18903802 |
| 72 | Absent frontal sinuses (HP:0002688) | 2.18646213 |
| 73 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.18420728 |
| 74 | Protruding tongue (HP:0010808) | 2.17520290 |
| 75 | Menstrual irregularities (HP:0000858) | 2.16318171 |
| 76 | Vertebral compression fractures (HP:0002953) | 2.14409601 |
| 77 | Inappropriate behavior (HP:0000719) | 2.13593622 |
| 78 | Palpitations (HP:0001962) | 2.12554763 |
| 79 | Poikilocytosis (HP:0004447) | 2.12487976 |
| 80 | Abnormality of the frontal sinuses (HP:0002687) | 2.12062415 |
| 81 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.11735770 |
| 82 | Irregular vertebral endplates (HP:0003301) | 2.11158553 |
| 83 | Mild short stature (HP:0003502) | 2.10126399 |
| 84 | Microglossia (HP:0000171) | 2.09724466 |
| 85 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.09304317 |
| 86 | Renal cortical cysts (HP:0000803) | 2.08416396 |
| 87 | Metaphyseal cupping (HP:0003021) | 2.07582623 |
| 88 | Disproportionate short-trunk short stature (HP:0003521) | 2.06109522 |
| 89 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.05632515 |
| 90 | Premature rupture of membranes (HP:0001788) | 2.05133140 |
| 91 | Reduced antithrombin III activity (HP:0001976) | 2.02984006 |
| 92 | Facial diplegia (HP:0001349) | 2.02138318 |
| 93 | Progressive sensorineural hearing impairment (HP:0000408) | 2.02001691 |
| 94 | Abnormal auditory evoked potentials (HP:0006958) | 2.01643517 |
| 95 | Ascites (HP:0001541) | 2.00902756 |
| 96 | Stomatitis (HP:0010280) | 2.00305800 |
| 97 | Methylmalonic aciduria (HP:0012120) | 1.99937848 |
| 98 | Increased mean platelet volume (HP:0011877) | 1.99721578 |
| 99 | Absent eyelashes (HP:0000561) | 1.99620976 |
| 100 | Neoplasm of the rectum (HP:0100743) | 1.99341409 |
| 101 | Abnormality of the pons (HP:0007361) | 1.99179110 |
| 102 | Cortical dysplasia (HP:0002539) | 1.98849392 |
| 103 | Stillbirth (HP:0003826) | 1.98281862 |
| 104 | Lower limb hyperreflexia (HP:0002395) | 1.98055453 |
| 105 | Aplasia/Hypoplasia of the phalanges of the 5th finger (HP:0009376) | 1.97636858 |
| 106 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 1.97389828 |
| 107 | Neoplasm of the small intestine (HP:0100833) | 1.96643228 |
| 108 | Resting tremor (HP:0002322) | 1.96411526 |
| 109 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.94897966 |
| 110 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.94897966 |
| 111 | Abnormality of macrophages (HP:0004311) | 1.94801050 |
| 112 | Ketoacidosis (HP:0001993) | 1.93212415 |
| 113 | Curly hair (HP:0002212) | 1.91936321 |
| 114 | Proximal tubulopathy (HP:0000114) | 1.91344260 |
| 115 | Protuberant abdomen (HP:0001538) | 1.90682523 |
| 116 | Acanthocytosis (HP:0001927) | 1.90572061 |
| 117 | Abnormal pancreas size (HP:0012094) | 1.89823650 |
| 118 | Abnormality of the vertebral endplates (HP:0005106) | 1.88993283 |
| 119 | Abnormal biliary tract morphology (HP:0012440) | 1.88764214 |
| 120 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.88702543 |
| 121 | Papillary thyroid carcinoma (HP:0002895) | 1.88502130 |
| 122 | Hypoproteinemia (HP:0003075) | 1.88226881 |
| 123 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.87889656 |
| 124 | Shoulder girdle muscle weakness (HP:0003547) | 1.87392656 |
| 125 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.87111215 |
| 126 | Open mouth (HP:0000194) | 1.86581648 |
| 127 | Azoospermia (HP:0000027) | 1.86408404 |
| 128 | Flattened epiphyses (HP:0003071) | 1.86155922 |
| 129 | Generalized hypopigmentation of hair (HP:0011358) | 1.85675070 |
| 130 | Glucose intolerance (HP:0000833) | 1.85362883 |
| 131 | Increased CSF protein (HP:0002922) | 1.84978077 |
| 132 | Upper limb muscle weakness (HP:0003484) | 1.84714865 |
| 133 | Blue irides (HP:0000635) | 1.84305350 |
| 134 | Drooling (HP:0002307) | 1.83834937 |
| 135 | Excessive salivation (HP:0003781) | 1.83834937 |
| 136 | Abnormality of vitamin metabolism (HP:0100508) | 1.83320295 |
| 137 | Aortic dissection (HP:0002647) | 1.81915920 |
| 138 | Cholecystitis (HP:0001082) | 1.81752764 |
| 139 | Abnormal gallbladder physiology (HP:0012438) | 1.81752764 |
| 140 | Hyperglycemia (HP:0003074) | 1.79918533 |
| 141 | Ankle contracture (HP:0006466) | 1.78873958 |
| 142 | Hypoplasia of the pons (HP:0012110) | 1.78649024 |
| 143 | Hypokinesia (HP:0002375) | 1.78052833 |
| 144 | Severe short stature (HP:0003510) | 1.77170522 |
| 145 | Ependymoma (HP:0002888) | 1.75849951 |
| 146 | Hypophosphatemic rickets (HP:0004912) | 1.74554977 |
| 147 | Horizontal nystagmus (HP:0000666) | 1.73972162 |
| 148 | Mediastinal lymphadenopathy (HP:0100721) | 1.72577066 |
| 149 | Abnormality of chromosome stability (HP:0003220) | 1.72280708 |
| 150 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.71533962 |
| 151 | Cupped ribs (HP:0000887) | 1.69951802 |
| 152 | Tubulointerstitial nephritis (HP:0001970) | 1.69660276 |
| 153 | Aortic aneurysm (HP:0004942) | 1.69165777 |
| 154 | Chromsome breakage (HP:0040012) | 1.68711799 |
| 155 | Hypoplasia of the fovea (HP:0007750) | 1.68572411 |
| 156 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.68572411 |
| 157 | Degeneration of anterior horn cells (HP:0002398) | 1.68563858 |
| 158 | Abnormality of the anterior horn cell (HP:0006802) | 1.68563858 |
| 159 | Entropion (HP:0000621) | 1.68382297 |
| 160 | Atonic seizures (HP:0010819) | 1.67662609 |
| 161 | Patchy hypopigmentation of hair (HP:0011365) | 1.66865840 |
| 162 | Abnormal foot bone ossification (HP:0010675) | 1.66783079 |
| 163 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.66766311 |
| 164 | Acute myeloid leukemia (HP:0004808) | 1.66712260 |
| 165 | Meningioma (HP:0002858) | 1.66493614 |
| 166 | Widely spaced teeth (HP:0000687) | 1.66479644 |
| 167 | Thyroid-stimulating hormone excess (HP:0002925) | 1.66428064 |
| 168 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.65724811 |
| 169 | Thoracolumbar scoliosis (HP:0002944) | 1.65507400 |
| 170 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.65449566 |
| 171 | Termporal pattern (HP:0011008) | 1.65419682 |
| 172 | Insidious onset (HP:0003587) | 1.65419682 |
| 173 | Spondylolisthesis (HP:0003302) | 1.65020624 |
| 174 | Gait imbalance (HP:0002141) | 1.64291749 |
| 175 | Relative macrocephaly (HP:0004482) | 1.62355899 |
| 176 | Biconcave vertebral bodies (HP:0004586) | 1.62064637 |
| 177 | Deep palmar crease (HP:0006191) | 1.61752163 |
| 178 | Abnormality of dentin (HP:0010299) | 1.60778490 |
| 179 | Action tremor (HP:0002345) | 1.59850194 |
| 180 | Short nail (HP:0001799) | 1.59710457 |
| 181 | Pectus carinatum (HP:0000768) | 1.59491328 |
| 182 | Congenital primary aphakia (HP:0007707) | 1.56823300 |
| 183 | Dilatation of the ascending aorta (HP:0005111) | 1.56637216 |
| 184 | Wormian bones (HP:0002645) | 1.56541092 |
| 185 | Cystic hygroma (HP:0000476) | 1.53907799 |
| 186 | Spinal muscular atrophy (HP:0007269) | 1.53654973 |
| 187 | Cubitus valgus (HP:0002967) | 1.53216910 |
| 188 | Interstitial pulmonary disease (HP:0006530) | 1.52942479 |
| 189 | Hypoplastic labia majora (HP:0000059) | 1.52014066 |
| 190 | Mitral stenosis (HP:0001718) | 1.51058703 |
| 191 | Apathy (HP:0000741) | 1.48252155 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | AKT3 | 5.57946273 |
| 2 | EIF2AK1 | 3.93122796 |
| 3 | RIPK4 | 3.49039749 |
| 4 | MST4 | 3.17275417 |
| 5 | ACVR1B | 3.01482032 |
| 6 | ERBB3 | 2.97717485 |
| 7 | FRK | 2.67437628 |
| 8 | NEK1 | 2.46467660 |
| 9 | TAOK3 | 2.37101806 |
| 10 | NEK9 | 2.33471192 |
| 11 | SGK2 | 2.23539809 |
| 12 | MAP3K2 | 2.17087428 |
| 13 | CASK | 2.11637653 |
| 14 | TRIM28 | 2.01384669 |
| 15 | EIF2AK3 | 1.97658625 |
| 16 | IRAK4 | 1.95726006 |
| 17 | INSRR | 1.94300430 |
| 18 | SRPK1 | 1.86543860 |
| 19 | EPHA3 | 1.84251294 |
| 20 | MAP3K12 | 1.83639504 |
| 21 | IRAK3 | 1.81062227 |
| 22 | CAMKK2 | 1.78970243 |
| 23 | PRKD3 | 1.72201450 |
| 24 | MAP3K14 | 1.65936644 |
| 25 | PLK3 | 1.62456105 |
| 26 | SGK3 | 1.59718743 |
| 27 | SGK223 | 1.55752222 |
| 28 | SGK494 | 1.55752222 |
| 29 | EPHB1 | 1.55115809 |
| 30 | SCYL2 | 1.52813732 |
| 31 | PLK2 | 1.48500133 |
| 32 | IRAK1 | 1.36872492 |
| 33 | TSSK6 | 1.36705741 |
| 34 | MARK3 | 1.33739808 |
| 35 | ERBB4 | 1.33211684 |
| 36 | MYLK | 1.27583672 |
| 37 | MKNK2 | 1.27475837 |
| 38 | TYK2 | 1.26884221 |
| 39 | BCR | 1.20329844 |
| 40 | TTK | 1.18898752 |
| 41 | TGFBR2 | 1.18346167 |
| 42 | NTRK3 | 1.16170944 |
| 43 | TNIK | 1.15529764 |
| 44 | TBK1 | 1.14290780 |
| 45 | PRKCH | 1.13219040 |
| 46 | MAPK13 | 1.12824567 |
| 47 | KSR1 | 1.11866381 |
| 48 | MAP3K4 | 1.11551008 |
| 49 | FLT3 | 1.10036624 |
| 50 | STK38L | 1.09306166 |
| 51 | TYRO3 | 1.08824557 |
| 52 | TRPM7 | 1.08179770 |
| 53 | PDGFRB | 1.06835364 |
| 54 | NEK6 | 1.06418365 |
| 55 | MAPK15 | 1.05963321 |
| 56 | JAK1 | 1.05431456 |
| 57 | CSF1R | 1.04378169 |
| 58 | PDGFRA | 1.03690488 |
| 59 | BMPR1B | 1.03174930 |
| 60 | BMPR2 | 1.02964803 |
| 61 | BRSK2 | 1.02293543 |
| 62 | EIF2AK2 | 0.97972485 |
| 63 | NUAK1 | 0.97255143 |
| 64 | JAK3 | 0.96991316 |
| 65 | STK3 | 0.94700613 |
| 66 | DDR2 | 0.93711640 |
| 67 | FGFR3 | 0.92088971 |
| 68 | STK39 | 0.90740173 |
| 69 | EPHA4 | 0.89886631 |
| 70 | MARK1 | 0.89805383 |
| 71 | MKNK1 | 0.88993903 |
| 72 | PIK3CG | 0.88421188 |
| 73 | CSK | 0.88338822 |
| 74 | CAMK1D | 0.85647103 |
| 75 | SGK1 | 0.85465156 |
| 76 | YES1 | 0.85246823 |
| 77 | WNK3 | 0.84837807 |
| 78 | PLK4 | 0.81600156 |
| 79 | TGFBR1 | 0.81360717 |
| 80 | NTRK2 | 0.81245439 |
| 81 | BUB1 | 0.80902982 |
| 82 | TTN | 0.80663154 |
| 83 | BRAF | 0.80417756 |
| 84 | STK16 | 0.79397415 |
| 85 | PRKCE | 0.78864113 |
| 86 | CHUK | 0.78317847 |
| 87 | OXSR1 | 0.77229120 |
| 88 | PASK | 0.76746032 |
| 89 | MST1R | 0.75823855 |
| 90 | FES | 0.74800647 |
| 91 | FGR | 0.73930951 |
| 92 | PAK3 | 0.72680420 |
| 93 | WEE1 | 0.71088276 |
| 94 | RAF1 | 0.71045116 |
| 95 | BRD4 | 0.68668902 |
| 96 | TEC | 0.67538331 |
| 97 | LATS1 | 0.66285701 |
| 98 | PTK2B | 0.64840281 |
| 99 | RPS6KA2 | 0.64733486 |
| 100 | GSK3A | 0.64165598 |
| 101 | PLK1 | 0.63118621 |
| 102 | NEK2 | 0.63074989 |
| 103 | MAP2K1 | 0.62525856 |
| 104 | PDK2 | 0.62120533 |
| 105 | IRAK2 | 0.60941252 |
| 106 | HIPK2 | 0.60735584 |
| 107 | PBK | 0.60479162 |
| 108 | ERN1 | 0.60313481 |
| 109 | CCNB1 | 0.60281911 |
| 110 | MAP2K4 | 0.58548592 |
| 111 | FER | 0.58316928 |
| 112 | BMX | 0.57739885 |
| 113 | PTK2 | 0.56892210 |
| 114 | PAK2 | 0.56020085 |
| 115 | RET | 0.55647801 |
| 116 | PIM1 | 0.54575404 |
| 117 | ZAK | 0.54567526 |
| 118 | HCK | 0.53085798 |
| 119 | PHKG2 | 0.52125725 |
| 120 | PHKG1 | 0.52125725 |
| 121 | MET | 0.51317386 |
| 122 | PDK3 | 0.51202030 |
| 123 | PDK4 | 0.51202030 |
| 124 | KSR2 | 0.51189180 |
| 125 | CLK1 | 0.47519783 |
| 126 | IKBKE | 0.46669071 |
| 127 | TIE1 | 0.45672155 |
| 128 | PIK3CA | 0.45215016 |
| 129 | SIK3 | 0.45014610 |
| 130 | VRK1 | 0.44900245 |
| 131 | ADRBK2 | 0.44529427 |
| 132 | MAP3K5 | 0.44340667 |
| 133 | IGF1R | 0.43318001 |
| 134 | ATM | 0.43117508 |
| 135 | MAP2K3 | 0.42417706 |
| 136 | STK24 | 0.41804361 |
| 137 | STK10 | 0.41720651 |
| 138 | BRSK1 | 0.41461498 |
| 139 | NTRK1 | 0.41161436 |
| 140 | PRKG2 | 0.40540546 |
| 141 | CDK9 | 0.39993469 |
| 142 | EGFR | 0.39969332 |
| 143 | GRK7 | 0.39729538 |
| 144 | PTK6 | 0.39419652 |
| 145 | DMPK | 0.39413420 |
| 146 | MUSK | 0.39412814 |
| 147 | IKBKB | 0.38436719 |
| 148 | CAMK1G | 0.38272685 |
| 149 | PRKACB | 0.37414210 |
| 150 | CDK6 | 0.36897030 |
| 151 | PKN2 | 0.36260658 |
| 152 | INSR | 0.36235379 |
| 153 | OBSCN | 0.36067610 |
| 154 | MAPK7 | 0.35835270 |
| 155 | CAMKK1 | 0.35609123 |
| 156 | RPS6KB1 | 0.35538058 |
| 157 | MOS | 0.34787515 |
| 158 | ABL1 | 0.33056801 |
| 159 | FGFR1 | 0.31824804 |
| 160 | MAP4K2 | 0.29222552 |
| 161 | GRK1 | 0.28272418 |
| 162 | RPS6KA4 | 0.28029921 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Caffeine metabolism_Homo sapiens_hsa00232 | 6.45836704 |
| 2 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.74947774 |
| 3 | Basal transcription factors_Homo sapiens_hsa03022 | 2.49173522 |
| 4 | Proteasome_Homo sapiens_hsa03050 | 2.46810089 |
| 5 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.31328866 |
| 6 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.04517102 |
| 7 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.04470325 |
| 8 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.03716018 |
| 9 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.01718651 |
| 10 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.97431975 |
| 11 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.84833605 |
| 12 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.80356719 |
| 13 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.78238909 |
| 14 | Phagosome_Homo sapiens_hsa04145 | 1.72613136 |
| 15 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.72530138 |
| 16 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.72484537 |
| 17 | Lysosome_Homo sapiens_hsa04142 | 1.67121120 |
| 18 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.63879607 |
| 19 | RNA degradation_Homo sapiens_hsa03018 | 1.63687486 |
| 20 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.63458163 |
| 21 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.59995540 |
| 22 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.58731467 |
| 23 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.57386606 |
| 24 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.52862352 |
| 25 | Leishmaniasis_Homo sapiens_hsa05140 | 1.50719004 |
| 26 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.49841488 |
| 27 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.49271125 |
| 28 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.46001950 |
| 29 | Legionellosis_Homo sapiens_hsa05134 | 1.43894411 |
| 30 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.43557818 |
| 31 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.43262737 |
| 32 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.42258766 |
| 33 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.39443231 |
| 34 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.38933554 |
| 35 | RNA transport_Homo sapiens_hsa03013 | 1.38034182 |
| 36 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.34103201 |
| 37 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.34042576 |
| 38 | Tuberculosis_Homo sapiens_hsa05152 | 1.31434832 |
| 39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.23301467 |
| 40 | RNA polymerase_Homo sapiens_hsa03020 | 1.19220303 |
| 41 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.19135938 |
| 42 | Pertussis_Homo sapiens_hsa05133 | 1.18041111 |
| 43 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.15034609 |
| 44 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.14555990 |
| 45 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.14251518 |
| 46 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.12405013 |
| 47 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.10978005 |
| 48 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.10954386 |
| 49 | Protein export_Homo sapiens_hsa03060 | 1.10588788 |
| 50 | Cell cycle_Homo sapiens_hsa04110 | 1.09336568 |
| 51 | Phototransduction_Homo sapiens_hsa04744 | 1.08992957 |
| 52 | Peroxisome_Homo sapiens_hsa04146 | 1.08676187 |
| 53 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.07403335 |
| 54 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.07292231 |
| 55 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.04533082 |
| 56 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.04139585 |
| 57 | Other glycan degradation_Homo sapiens_hsa00511 | 1.03590783 |
| 58 | Long-term depression_Homo sapiens_hsa04730 | 1.03026171 |
| 59 | Long-term potentiation_Homo sapiens_hsa04720 | 1.02906506 |
| 60 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.02327231 |
| 61 | Malaria_Homo sapiens_hsa05144 | 1.01952253 |
| 62 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.01506736 |
| 63 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.01431743 |
| 64 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.00722052 |
| 65 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.99123492 |
| 66 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.98850672 |
| 67 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.98638754 |
| 68 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.98543206 |
| 69 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.97941437 |
| 70 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.95763565 |
| 71 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.95278148 |
| 72 | Insulin secretion_Homo sapiens_hsa04911 | 0.95078153 |
| 73 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.94942224 |
| 74 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.94618513 |
| 75 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.94039500 |
| 76 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.93460258 |
| 77 | Amoebiasis_Homo sapiens_hsa05146 | 0.92446492 |
| 78 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.90506673 |
| 79 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.90319569 |
| 80 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.89991084 |
| 81 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.89418939 |
| 82 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.88921348 |
| 83 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.88522527 |
| 84 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.88262624 |
| 85 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.87914875 |
| 86 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.87704663 |
| 87 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.87483236 |
| 88 | Insulin resistance_Homo sapiens_hsa04931 | 0.86651041 |
| 89 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.86563974 |
| 90 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.86529634 |
| 91 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.86204973 |
| 92 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.86195447 |
| 93 | Prion diseases_Homo sapiens_hsa05020 | 0.86147745 |
| 94 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.85973274 |
| 95 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.85725265 |
| 96 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.85598425 |
| 97 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.85398890 |
| 98 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.85391871 |
| 99 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.84780537 |
| 100 | Focal adhesion_Homo sapiens_hsa04510 | 0.84776072 |
| 101 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.84711726 |
| 102 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.83387199 |
| 103 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.83118687 |
| 104 | Hepatitis C_Homo sapiens_hsa05160 | 0.82158961 |
| 105 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.81683914 |
| 106 | Circadian entrainment_Homo sapiens_hsa04713 | 0.79141724 |
| 107 | Glioma_Homo sapiens_hsa05214 | 0.78453411 |
| 108 | Influenza A_Homo sapiens_hsa05164 | 0.77757739 |
| 109 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.77044427 |
| 110 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.76644132 |
| 111 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.76170628 |
| 112 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.75603450 |
| 113 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.75329754 |
| 114 | Platelet activation_Homo sapiens_hsa04611 | 0.74532849 |
| 115 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.74462739 |
| 116 | Adherens junction_Homo sapiens_hsa04520 | 0.74113641 |
| 117 | Circadian rhythm_Homo sapiens_hsa04710 | 0.73712911 |
| 118 | Salmonella infection_Homo sapiens_hsa05132 | 0.73672933 |
| 119 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.72737353 |
| 120 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.72585294 |
| 121 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.72313903 |
| 122 | Measles_Homo sapiens_hsa05162 | 0.71963309 |
| 123 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.71941764 |
| 124 | Morphine addiction_Homo sapiens_hsa05032 | 0.71705810 |
| 125 | Mineral absorption_Homo sapiens_hsa04978 | 0.71604393 |
| 126 | Mismatch repair_Homo sapiens_hsa03430 | 0.71546243 |
| 127 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.71378131 |
| 128 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.70685150 |
| 129 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.69803516 |
| 130 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.69406664 |
| 131 | Renin secretion_Homo sapiens_hsa04924 | 0.69222586 |
| 132 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.68589465 |
| 133 | Olfactory transduction_Homo sapiens_hsa04740 | 0.68063617 |
| 134 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.67832003 |
| 135 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.67651604 |
| 136 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.66182255 |
| 137 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.65994581 |
| 138 | Prostate cancer_Homo sapiens_hsa05215 | 0.64079049 |
| 139 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.63630453 |
| 140 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.63255598 |
| 141 | Shigellosis_Homo sapiens_hsa05131 | 0.62372288 |
| 142 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.62208278 |
| 143 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.61797543 |
| 144 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.61613142 |
| 145 | Hepatitis B_Homo sapiens_hsa05161 | 0.61183631 |
| 146 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.60764673 |
| 147 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.60665450 |
| 148 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.59190041 |
| 149 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.58257508 |
| 150 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.57111083 |
| 151 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.56666375 |
| 152 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.56361277 |
| 153 | Retinol metabolism_Homo sapiens_hsa00830 | 0.56209910 |
| 154 | Homologous recombination_Homo sapiens_hsa03440 | 0.55740351 |
| 155 | Axon guidance_Homo sapiens_hsa04360 | 0.55478601 |
| 156 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.55242140 |
| 157 | Apoptosis_Homo sapiens_hsa04210 | 0.54898278 |
| 158 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.54867904 |
| 159 | Endometrial cancer_Homo sapiens_hsa05213 | 0.54580406 |
| 160 | GABAergic synapse_Homo sapiens_hsa04727 | 0.54517385 |
| 161 | Gap junction_Homo sapiens_hsa04540 | 0.54251041 |
| 162 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.50492210 |
| 163 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.49958837 |
| 164 | Metabolic pathways_Homo sapiens_hsa01100 | 0.48687499 |
| 165 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.45685953 |
| 166 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.44940578 |
| 167 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.42771680 |
| 168 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.42064699 |
| 169 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.40508209 |
| 170 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.36961736 |
| 171 | Thyroid cancer_Homo sapiens_hsa05216 | 0.36904280 |
| 172 | ABC transporters_Homo sapiens_hsa02010 | 0.35055310 |
| 173 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.34955065 |
| 174 | Purine metabolism_Homo sapiens_hsa00230 | 0.34469892 |
| 175 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.34467311 |
| 176 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.34356247 |
| 177 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.31414792 |
| 178 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.29395408 |
| 179 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.26388064 |
| 180 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.24961409 |

